Re: no evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
Gillman
P K
PK
D000928:Antidepressive Agents / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005473:Fluoxetine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008657:Metabolic Clearance Rate / Q000235:genetics*; D009661:Nortriptyline / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D011110:Polymorphism, Genetic
D000928:Antidepressive Agents; D005473:Fluoxetine; D009661:Nortriptyline; D019389:Cytochrome P-450 CYP2D6